Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Advanced Brain Technologies is a private U.S. neurotechnology and healthcare company that develops neuroscience-based music listening and rhythm programs intended to support brain health, auditory processing, sensory integration, communication, focus, and sleep. Its core commercial offerings include The Listening Program, inTime, Sleep Genius, BrainBuilder, and Waves audio hardware, which are sold to both consumers and professional users such as therapists, educators, clinics, hospitals, schools, and military or veterans-related settings. The company positions its products as evidence-based, non-pharmacological interventions built from collaborations among therapists, scientists, musicians, sound engineers, and technologists. Rather than a drug developer, ABT operates as a commercial-stage brain health and therapeutic listening company focused on digital, audio, and device-enabled interventions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Brain Technologies.